At Allogene, our mission is to create the next revolution in cancer treatment by leading the development of allogeneic CAR T cell (AlloCAR TTM) therapies for cancer. With this goal, we are setting out to do something that has never been done before. We recognize that it won’t be easy and will require a lot of hard work, expertise, and dedication. As a team working together, we believe we can make AlloCARsTM a reality for patients and change how cancer is treated.
- We have an experienced, high-performance and growing team of employees whose sole focus is to transform the treatment of cancer.
- We have a deep pipeline of innovative AlloCAR TTM therapies.
- We have an allogeneic platform based on validated gene editing and advanced proprietary cell manufacturing technologies.
- We are on our way to building a culture and a company focused on working collaboratively to do something life-changing for cancer patients.
Our four values – Innovate, Focus, Collaborate and Lead – are core to our organization and how we conduct ourselves every day.
We are rooted in science and innovative in our approach to finding better solutions for treating cancer.
We are focused on AlloCAR TTM therapy, our mission and our commitment to patients.
We are one team collaborating toward one vision.
We have the expertise and courage to take calculated risks in order to lead the next revolution in the treatment of cancer.